T-knife - Crunchbase Company Profile & Funding

Q: Where is T-knife's headquarters?

T-knife is located in Berlin, Berlin, Germany.

Q: Who invested in T-knife?

T-knife has 10 investors including Casdin Capital And Versant Ventures.

Q: When was the last funding round for T-knife?

T-knife closed its last funding round on obfuscated from a Series B round.

Overview

T-knife

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About T-knife

CB Rank

28985

T-knife is a developer of T cell receptors intended for T cell therapy of cancer.

Founded

obfuscation

Private

Series B

Berlin, Berlin, Germany

51-100

t-knife.com/

Biotechnology

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Elisa Kieback: CTO and co-founder
Tom Soloway: Chief Executive Officer
Past Role: Audentes Therapeutics, Executive Vice President & Chief Operating Officer

Details

Legal Name

T-knife Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Elisa Kieback, Thomas Blankenstein

About the Company

T-knife is a developer of T cell receptors intended for T cell therapy of cancer.The company uses a humanized TCR mice platform to carry human TCRαβ gene loci and recombine a broad repertoire of human TCRs, enabling the efficient generation and virtual selection of cell receptors for any human tumor antigen.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

TK-6302

A T cell receptor engineered T cell therapy targeting the PRAME antigen in solid tumors to induce T cell-driven immune responses.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - T-knife	9	obfuscated obfuscation	Fidelity	Series B
obfuscated obfuscation	Series B - T-knife	9	obfuscated obfuscation	Fidelity	Series B
obfuscated obfuscation	Series B - T-knife	9	obfuscated obfuscation	Fidelity	Series B
obfuscated obfuscation	Series B - T-knife	9	obfuscated obfuscation	Fidelity	Series B
obfuscated obfuscation	Series B - T-knife	9	obfuscated obfuscation	Fidelity	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - T-knife	9	obfuscated obfuscation	Fidelity	Series B
obfuscated obfuscation	Series B - T-knife	9	obfuscated obfuscation	Fidelity	Series B
obfuscated obfuscation	Series B - T-knife	9	obfuscated obfuscation	Fidelity	Series B
obfuscated obfuscation	Series B - T-knife	9	obfuscated obfuscation	Fidelity	Series B
obfuscated obfuscation	Series B - T-knife	9	obfuscated obfuscation	Fidelity	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Casdin Capital	—	Series B - T-knife	—
Casdin Capital	—	Series B - T-knife	—
Casdin Capital	—	Series B - T-knife	—
Casdin Capital	—	Series B - T-knife	—
Casdin Capital	—	Series B - T-knife	—